BBGBloomberg·3hBusiness
score+0.70
Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO
Original
Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO
“Upbeat framing emphasizing successful capital raise, top-of-range pricing, and company backing signal strong market confidence.”